Circulating cell-free DNA undergoes significant decline in yield after prolonged storage time in both plasma and purified form
Author:
Yuwono Nicole Laurencia1ORCID, Boyd Mollie Ailie Acheson1, Henry Claire Elizabeth1, Werner Bonnita1, Ford Caroline Elizabeth1, Warton Kristina1ORCID
Affiliation:
1. Gynaecological Cancer Research Group, Adult Cancer Program, School of Women’s and Children’s Health, Faculty of Medicine and Health, Lowy Cancer Research Centre, University of New South Wales , Sydney , Australia
Abstract
Abstract
Objectives
Circulating DNA (cirDNA) is generally purified from plasma that has been biobanked for variable lengths of time. In long-term experiments or clinical trials, the plasma can be stored frozen for up to several years. Therefore, it is crucial to determine the stability of cirDNA to ensure confidence in sample quality upon analysis. Our main objective was to determine the effect of storage for up to 2 years on cirDNA yield and fragmentation.
Methods
We stored frozen EDTA plasma and purified cirDNA from 10 healthy female donors, then quantified cirDNA yield at baseline, and at regular intervals for up to 2 years, by qPCR and Qubit. We also compared cirDNA levels in non-haemolysed and haemolysed blood samples after 16 months of storage and tested the effect of varying DNA extraction protocol parameters.
Results
Storage up to two years caused an annual cirDNA yield decline of 25.5% when stored as plasma and 23% when stored as purified DNA, with short fragments lost more rapidly than long fragments. Additionally, cirDNA yield was impacted by plasma input and cirDNA elution volumes, but not by haemolysis.
Conclusions
The design of long-term cirDNA-based studies and clinical trials should factor in the deterioration of cirDNA during storage.
Funder
Beth Yarrow Memorial Award in Medical Science CAMILLA AND MARC Gynaecological Oncology Fund Translational Cancer Research Network Australian Research Training Program Ovarian Cancer Research Foundation
Publisher
Walter de Gruyter GmbH
Subject
Biochemistry (medical),Clinical Biochemistry,General Medicine
Reference24 articles.
1. Wan, JCM, Massie, C, Garcia-Corbacho, J, Mouliere, F, Brenton, JD, Caldas, C, et al.. Liquid biopsies come of age: towards implementation of circulating tumour DNA. Nat Rev Cancer 2017;17:223–38. https://doi.org/10.1038/nrc.2017.7. 2. Trigg, RM, Martinson, LJ, Parpart-Li, S, Shaw, JA. Factors that influence quality and yield of circulating-free DNA: a systematic review of the methodology literature. Heliyon 2018;4:e00699. https://doi.org/10.1016/j.heliyon.2018.e00699. 3. Sozzi, G, Roz, L, Conte, D, Mariani, L, Andriani, F, Verderio, P, et al.. Effects of prolonged storage of whole plasma or isolated plasma DNA on the results of circulating DNA quantification assays. J Natl Cancer Inst 2005;97:1848–50. https://doi.org/10.1093/jnci/dji432. 4. Sato, A, Nakashima, C, Abe, T, Kato, J, Hirai, M, Nakamura, T, et al.. Investigation of appropriate pre-analytical procedure for circulating free DNA from liquid biopsy. Oncotarget 2018;9:31904–14. https://doi.org/10.18632/oncotarget.25881. 5. Clausen, FB, Barrett, AN, Advani, HV, Choolani, M, Dziegiel, MH. Impact of long-term storage of plasma and cell-free DNA on measured DNA quantity and fetal fraction. Vox Sang 2020;115:586–94. https://doi.org/10.1111/vox.12923.
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|